← FDA Drug Approvals (Drugs@FDA)

LIALDA

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2007-01-16

Drug application

FDA Application #

NDA022000

Application type

New Drug Application

Brand name

LIALDA

Generic name

MESALAMINE

Active ingredients

MESALAMINE

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2007-01-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown